Trends and impact of antimicrobial resistance on older inpatients with urinary tract infections (UTIs): A national retrospective observational study

Autoři: Hoa Q. Nguyen aff001;  Nga T. Q. Nguyen aff002;  Carmel M. Hughes aff001;  Ciaran O’Neill aff002
Působiště autorů: School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom aff001;  Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom aff002
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article


Urinary tract infections (UTIs) are one of the most common infections in older people and are associated with increased morbidity and mortality. UTIs are also associated with increased risk of antimicrobial resistance (AR). This study examined changes in AR among older inpatients with a primary diagnosis of UTIs in the United States over an 8-year period and the impact of AR on clinical outcomes and hospital costs. Data were obtained from the longitudinal hospital HCUP-NIS database from 2009 to 2016 for inpatient episodes that involved those aged 65+ years. The ICD-9 and ICD-10 codes were used to identify episodes with a primary diagnosis of UTIs, comorbidities, AR status and age-adjusted Deyo-Charlson comorbidity index (ACCI) for the patient concerned. Weighted multivariable regression was used to examine the impact of AR on all-cause inpatient mortality, discharge destination, length of stay and hospital expenditures, adjusted for socio-demographic and clinical covariates. The proportion of admissions with AR increased, from 3.64% in 2009 to 6.88% in 2016 (p<0.001), with distinct patterns for different types of resistance. The likelihood of AR was higher in admissions with high ACCI scores and admissions to hospitals in urban areas. Admissions with AR were more likely to be discharged to healthcare facilities (e.g. care homes) compared to routine discharge (OR 1.81; 95%CI, 1.75–1.86), had increased length of stay (1.12 days; 95%CI, 1.06–1.18) and hospital costs (1259 USD; 95%CI, 1178–1340). Resistance due to MRSA was specifically associated with increased hospital mortality (OR 1.33; 95%CI, 1.15–1.53). Our findings suggest that the prevalence of AR has increased among older inpatients with UTIs in the USA. The study highlights the impact of AR among older inpatients with a primary diagnosis of UTIs on clinical outcomes and hospital costs. These relationships and their implications for the care homes to which patients are frequently discharged warrant further research.

Klíčová slova:

Antimicrobial resistance – Death rates – Health care facilities – Hospitals – Inpatients – Insurance – Methicillin-resistant Staphylococcus aureus – Urinary tract infections


1. Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–22. doi: 10.1016/j.cmi.2015.12.002 26706614

2. Centers for Disease Control and Prevention (CDC). Antibiotic/antimicrobial resistance [Internet]. [cited 2019 Jun 30].

3. de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? PLOS Med. 2016;13(11):e1002184. doi: 10.1371/journal.pmed.1002184 27898664

4. Thorpe KE, Joski P, Johnston KJ. Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually. Health Aff. 2018;37(4):662–9.

5. Harbarth S, Balkhy HH, Goossens H, Jarlier V, Kluytmans J, Laxminarayan R, et al. Antimicrobial resistance: one world, one fight! Antimicrob Resist Infect Control. 2015;4(1):49.

6. Smith P, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, et al. SHEA/APIC Guideline: Infection Prevention and Control in the Long-Term Care Facility. Infect Control Hosp Epidemiol. 2008;29(9):785–814. doi: 10.1086/592416 18767983

7. Detweiler K, Mayers D, Fletcher SG. Bacteruria and Urinary Tract Infections in the Elderly. Urol Clin North Am. 2015;42(4):561–8. doi: 10.1016/j.ucl.2015.07.002 26475952

8. Mouton CP, Bazaldua O V, Pierce B, Espino DV. Common infections in older adults. Am Fam Physician. 2001;63(2):257–68. 11201692

9. Peron EP, Hirsch AA, Jury LA, Jump RLP, Donskey CJ. Another Setting for Stewardship: High Rate of Unnecessary Antimicrobial Use in a Veterans Affairs Long-Term Care Facility. J Am Geriatr Soc. 2013;61(2):289–90. doi: 10.1111/jgs.12099 23405923

10. van Buul LW, van der Steen JT, Veenhuizen RB, Achterberg WP, Schellevis FG, Essink RTGM, et al. Antibiotic Use and Resistance in Long Term Care Facilities. J Am Med Dir Assoc. 2012;13(6):568.e1–568.e13.

11. Esposito S, Leone S, Noviello S, Ianniello F, Fiore M. Antibiotic resistance in long-term care facilities. New Microbiol. 2007;30(3):326–31. 17802920

12. Mainous AG, Diaz VA, Matheson EM, Gregorie SH, Hueston WJ. Trends in Hospitalizations with Antibiotic-Resistant Infections: U.S., 1997–2006. Public Health Rep. 2011;126(3):354–60. doi: 10.1177/003335491112600309 21553664

13. United Nations—Department of Economic and Social Affairs—Population Division. World Population Ageing [Internet]. 2015 [cited 2019 Jun 30].

14. Gharbi M, Drysdale JH, Lishman H, Goudie R, Molokhia M, Johnson AP, et al. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ. 2019;364:l525. doi: 10.1136/bmj.l525 30814048

15. Gopal Rao G, Patel M. Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era. J Antimicrob Chemother. 2008;63(1):5–6. doi: 10.1093/jac/dkn458 19022779

16. Lob SH, Nicolle LE, Hoban DJ, Kazmierczak KM, Badal RE, Sahm DF. Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014. Diagn Microbiol Infect Dis. 2016;85(4):459–65. doi: 10.1016/j.diagmicrobio.2016.04.022 27306116

17. Frazee BW, Trivedi T, Montgomery M, Petrovic DF, Yamaji R, Riley L. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common. Ann Emerg Med. 2018;72(4):449–56. doi: 10.1016/j.annemergmed.2018.05.006 29980462

18. Fagan M, Lindbæk M, Grude N, Reiso H, Romøren M, Skaare D, et al. Antibiotic resistance patterns of bacteria causing urinary tract infections in the elderly living in nursing homes versus the elderly living at home: an observational study. BMC Geriatr. 2015;15(1):98.

19. Agency for Healthcare Research and Quality. HCUP National (Nationwide) Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP) [Internet]. [cited 2019 Jun 30].

20. Schultz L, Lowe TJ, Srinivasan A, Neilson D, Pugliese G. Economic Impact of Redundant Antimicrobial Therapy in US Hospitals. Infect Control Hosp Epidemiol. 2014;35(10):1229–35. doi: 10.1086/678066 25203175

21. Ricardo Rodrigues, Manfred Huber, Giovanni Lamura. Facts and Figures on Healthy Ageing and Long-term Care [Internet]. Vienna; 2012 [cited 2019 Jun 30].

22. Agency for Healthcare Research and Quality. AHRQ Quality Indicators ICD-9-CM and ICD-10-CM/ PCS Specification Enhanced Version 5.0 Prevention Quality Indicators #12 Urinary Tract Infection Admission Rate [Internet]. 2015 [cited 2019 Jun 30].

23. de Kraker MEA, Davey PG, Grundmann H, group B study. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011/10/11. 2011;8(10):e1001104–e1001104. doi: 10.1371/journal.pmed.1001104 22022233

24. Burnham JP, Kwon JH, Babcock HM, Olsen MA, Kollef MH. ICD-9-CM Coding for Multidrug Resistant Infection Correlates Poorly With Microbiologically Confirmed Multidrug Resistant Infection. Infect Control Hosp Epidemiol. 2017;38(11):1381–3. doi: 10.1017/ice.2017.192 28870271

25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373–83. doi: 10.1016/0021-9681(87)90171-8 3558716

26. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9. doi: 10.1016/0895-4356(92)90133-8 1607900

27. Abou Chakra CN, Pepin J, Sirard S, Valiquette L. Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review. PLoS One. 2014;9(6):e98400. doi: 10.1371/journal.pone.0098400 24897375

28. Olesen SW, Grad YH. Racial/ethnic disparities in antimicrobial drug use, United States, 2014–2015. Emerg Infect Dis. 2018;24(11):2126–8. doi: 10.3201/eid2411.180762 30334733

29. Collignon P, Beggs JJ, Walsh TR, Gandra S, Laxminarayan R. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. Lancet Planet Heal. 2018;2(9):e398–405.

30. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23(3):163–7. doi: 10.1007/s10096-003-1084-2 14986159

31. Laudisio A, Marinosci F, Gemma A, Bartoli IR, Montenegro N, Incalzi RA. The Burden of Comorbidity Is Associated with Antibiotic Resistance Among Institutionalized Elderly with Urinary Infection: A Retrospective Cohort Study in a Single Italian Nursing Home Between 2009 and 2014. Microb Drug Resist. 2016;23(4):500–6. doi: 10.1089/mdr.2016.0016 27525808

32. Dunn A, Grosse SD, Zuvekas SH. Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States. Health Serv Res. 2016;53(1):175–96. doi: 10.1111/1475-6773.12612 27873305

33. FRED Economic Data. Personal consumption expenditures: Services: Health care (chain-type price index) [Internet]. 2018 [cited 2019 Jun 30].

34. Deb P, Norton EC, Manning WG. Health econometrics using Stata. 1st ed. Stata Press; 2017.

35. Lichtenberger P, Hooton TM. Complicated urinary tract infections. Curr Infect Dis Rep. 2008;10(6):499–504. 18945392

36. Simmering JE, Tang F, Cavanaugh JE, Polgreen LA, Polgreen PM. The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998–2011. Open forum Infect Dis. 2017;4(1):ofw281. doi: 10.1093/ofid/ofw281 28480273

37. Klein EY, Mojica N, Jiang W, Cosgrove SE, Septimus E, Morgan DJ, et al. Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010–2014. Clin Infect Dis. 2017;65(11):1921–3. doi: 10.1093/cid/cix640 29020322

38. Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, et al. Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections—United States. MMWR Morb Mortal Wkly Rep. 2019;68:214–219. doi: 10.15585/mmwr.mm6809e1 30845118

39. Schweizer ML, Eber MR, Laxminarayan R, Furuno JP, Popovich KJ, Hota B, et al. Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol. 2011;32(2):148–54. doi: 10.1086/657936 21460469

40. Dyar OJ, Huttner B, Schouten J, Pulcini C. What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23(11):793–8. doi: 10.1016/j.cmi.2017.08.026 28882725

41. Nouvenne A, Ticinesi A, Lauretani F, Maggio M, Lippi G, Guida L, et al. Comorbidities and Disease Severity as Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Colonization: Report of an Experience in an Internal Medicine Unit. PLoS One. 2014;9(10):e110001. doi: 10.1371/journal.pone.0110001 25335100

42. Sahuquillo-Arce JM, Selva M, Perpiñán H, Gobernado M, Armero C, López-Quílez A, et al. Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location. Antimicrob Agents Chemother. 2011;55(3):1222–8. doi: 10.1128/AAC.00765-10 21220537

43. Versporten A, Zarb P, Caniaux I, Gros M-F, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Heal. 2018;6(6):e619–29.

44. Smith DL, Levin SA, Laxminarayan R. Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci U S A. 2005;102(8):3153–8. doi: 10.1073/pnas.0409523102 15677330

45. Collignon P, Athukorala P-C, Senanayake S, Khan F. Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem. PLoS One. 2015;10(3):e0116746–e0116746. doi: 10.1371/journal.pone.0116746 25786027

46. Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018;7:58. doi: 10.1186/s13756-018-0336-y 29713465

47. Cosgrove SE. The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs. Clin Infect Dis. 2006;42(Suppl 2):S82–9.

48. Oxenham D, Finucane A, Arnold E, Russell P. Delivering preference for place of death in a specialist palliative care setting. BMJ Qual Improv Reports. 2013;2(1):u201375.w897.

49. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria. Antimicrob Agents Chemother. 2009;54(1):109–15. doi: 10.1128/AAC.01041-09 19841152

50. Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know? Clin Microbiol Infect. 2014;20(10):973–80. doi: 10.1111/1469-0691.12798 25273968

51. Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2013/11/17. 2014;69(6):640–9. doi: 10.1093/gerona/glt162 24249734

52. Basic D, Shanley C. Frailty in an Older Inpatient Population: Using the Clinical Frailty Scale to Predict Patient Outcomes. J Aging Health. 2014;27(4):670–85. doi: 10.1177/0898264314558202 25414168

53. Gilardi F, Scarcella P, Proietti MG, Capobianco G, Rocco G, Capanna A, et al. Frailty as a predictor of mortality and hospital services use in older adults: a cluster analysis in a cohort study. Eur J Public Health. 2018;28(5):842–6. doi: 10.1093/eurpub/cky006 29590362

54. Bandeen-Roche K, Seplaki CL, Huang J, Buta B, Kalyani RR, Varadhan R, et al. Frailty in Older Adults: A Nationally Representative Profile in the United States. J Gerontol A Biol Sci Med Sci. 2015/08/21. 2015;70(11):1427–34. doi: 10.1093/gerona/glv133 26297656

Článek vyšel v časopise


2019 Číslo 10
Nejčtenější tento týden